Carebastine

CAS No. 90729-42-3

Carebastine ( —— )

Catalog No. M26088 CAS No. 90729-42-3

Carebastine, the active metabolite of Ebastine, is an antagonist of the histamine H1 receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 33 In Stock
5MG 53 In Stock
10MG 87 In Stock
25MG 177 In Stock
50MG 264 In Stock
100MG 393 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Carebastine
  • Note
    Research use only, not for human use.
  • Brief Description
    Carebastine, the active metabolite of Ebastine, is an antagonist of the histamine H1 receptor.
  • Description
    Carebastine, the active metabolite of Ebastine, is an antagonist of the histamine H1 receptor.(In Vitro):Carebastine inhibits VEGF-induced HPAEC and HUVEC proliferation, migration, and angiogenesis in a dose-dependent manner . Carebastine suppresses the expression of macrophage migration inhibitory factor .
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Histamine Receptor
  • Recptor
    Parasite
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    90729-42-3
  • Formula Weight
    499.7
  • Molecular Formula
    C32H37NO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)(C(O)=O)c1ccc(cc1)C(=O)CCCN1CCC(CC1)OC(c1ccccc1)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Computer-aided analysis of phytochemicals as potential dengue virus inhibitors based on molecular docking, ADMET and DFT studies.J Vector Borne Dis. 2017 Jul-Sep;54(3):255-262.
molnova catalog
related products
  • PF-03654764

    PF-03654764 (PF 3654764) is a potent, selective, orally bioactive antagonist of H3 receptor with Ki of 1.4 nM.

  • Cetirizine

    A second-generation antihistamine that acts as a selective H1 receptor antagonist; used in the treatment of allergies.AllergyApproved

  • JNJ-18038683

    JNJ-18038683 is a potent, selective 5-HT7 receptor antagonist with pKi of 8.19 and 8.20 for rat and human 5-HT7 in cell-based assays; decreases 5-HT (100 nM)-stimulated adenylyl cyclase in rat and human 5-HT7/HEK293 cells with pKb of 8.01 and 7.99, respectively.